GB1463505A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB1463505A
GB1463505A GB5409873A GB5409873A GB1463505A GB 1463505 A GB1463505 A GB 1463505A GB 5409873 A GB5409873 A GB 5409873A GB 5409873 A GB5409873 A GB 5409873A GB 1463505 A GB1463505 A GB 1463505A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
hydroxyacetanilide
cysteine
nov
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5409873A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Research Development Corp UK
National Research Development Corp of India
Original Assignee
National Research Development Corp UK
National Research Development Corp of India
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Research Development Corp UK, National Research Development Corp of India filed Critical National Research Development Corp UK
Priority to GB5409873A priority Critical patent/GB1463505A/en
Priority to ZA00747276A priority patent/ZA747276B/en
Priority to AU75378/74A priority patent/AU494300B2/en
Priority to FR7438224A priority patent/FR2251319B1/fr
Priority to CA214,254A priority patent/CA1028247A/en
Priority to DE19742455203 priority patent/DE2455203A1/en
Publication of GB1463505A publication Critical patent/GB1463505A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1463505 Pharmaceutical compositions NATIONAL RESEARCH DEVELOPMENT CORP 7 Nov 1974 [21 Nov 1973] 54098/73 Heading A5B Pharmaceutical compositions comprising the analgesic and antipyretic p-hydroxyacetanilide (acetaminophen, paracetamol) and L- cysteine or a compound which is converted thereto in vivo or a salt thereof such as a sulphur-containing amino acid or a peptide containing such an amino acid as a unit thereof e.g. cystine, methionine, L-glutamyl-L-cysteine and L-cysteinyl glycine directly counter the toxicity of an overdose, of the p-hydroxyacetanilide without reducing its normal beneficial action. The compositions may be administered orally in the form of tablets or elixirs and may also contain caffeine, caffeine hydrate, codeine, codeine phosphate, dihydrocodeine tartrate, pseudoephedrine hydrochloride and/or phenolphthalein.
GB5409873A 1973-11-21 1973-11-21 Pharmaceutical compositions Expired GB1463505A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB5409873A GB1463505A (en) 1973-11-21 1973-11-21 Pharmaceutical compositions
ZA00747276A ZA747276B (en) 1973-11-21 1974-11-13 Pharmaceutical compositions
AU75378/74A AU494300B2 (en) 1973-11-21 1974-11-14 Pharmaceutical compositions
FR7438224A FR2251319B1 (en) 1973-11-21 1974-11-20
CA214,254A CA1028247A (en) 1973-11-21 1974-11-20 Pharmaceutical compositions containing p-hydroxyacetanilide
DE19742455203 DE2455203A1 (en) 1973-11-21 1974-11-21 PHARMACEUTICAL PRODUCT CONTAINING P-HYDROXYACETANILIDE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5409873A GB1463505A (en) 1973-11-21 1973-11-21 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB1463505A true GB1463505A (en) 1977-02-02

Family

ID=10469907

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5409873A Expired GB1463505A (en) 1973-11-21 1973-11-21 Pharmaceutical compositions

Country Status (5)

Country Link
CA (1) CA1028247A (en)
DE (1) DE2455203A1 (en)
FR (1) FR2251319B1 (en)
GB (1) GB1463505A (en)
ZA (1) ZA747276B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2177917A (en) * 1985-07-09 1987-02-04 Aws Shakir Mustafa Salim Dermatologically active substances
WO1994020086A1 (en) * 1993-03-12 1994-09-15 British Technology Group Limited Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof
US6048540A (en) * 1997-01-29 2000-04-11 Chong Kun Dang Corp. Acetamenophen composition with reduced liver toxicity
WO2001068069A2 (en) * 2000-03-15 2001-09-20 King's College London Pharmaceutical composition comprising paracetamol
KR100379155B1 (en) * 2000-07-18 2003-04-08 삼진제약주식회사 New analgesic composition

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1583602A (en) * 1977-05-26 1981-01-28 Sterwin Ag N-acetyl-para-aminophenyl-n'-acetyl-amino-thioalkanoic acid ester derivatives
US4414212A (en) * 1981-12-10 1983-11-08 Graham J. Naylor Method of treatment of pre-menstrual syndrome

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1241201A (en) * 1968-07-23 1971-08-04 Sterling Winthrop Group Ltd Improvements in or relating to effervescent pharmaceutical compositions

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2177917A (en) * 1985-07-09 1987-02-04 Aws Shakir Mustafa Salim Dermatologically active substances
GB2177917B (en) * 1985-07-09 1990-01-17 Aws Shakir Mustafa Salim Dermatologically active substances
WO1994020086A1 (en) * 1993-03-12 1994-09-15 British Technology Group Limited Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof
GB2276319A (en) * 1993-03-12 1994-09-28 British Tech Group Paracetamol compositions
AU674934B2 (en) * 1993-03-12 1997-01-16 Penn Pharmaceutical Services Limited Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof
US5716991A (en) * 1993-03-12 1998-02-10 British Technology Group Limited Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof
US5852055A (en) * 1993-03-12 1998-12-22 Btg International Limited Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof
US6048540A (en) * 1997-01-29 2000-04-11 Chong Kun Dang Corp. Acetamenophen composition with reduced liver toxicity
WO2001068069A2 (en) * 2000-03-15 2001-09-20 King's College London Pharmaceutical composition comprising paracetamol
WO2001068069A3 (en) * 2000-03-15 2002-04-11 King S College London Pharmaceutical composition comprising paracetamol
KR100379155B1 (en) * 2000-07-18 2003-04-08 삼진제약주식회사 New analgesic composition

Also Published As

Publication number Publication date
DE2455203C2 (en) 1987-07-23
FR2251319B1 (en) 1978-07-21
FR2251319A1 (en) 1975-06-13
AU7537874A (en) 1976-05-20
ZA747276B (en) 1976-07-28
CA1028247A (en) 1978-03-21
DE2455203A1 (en) 1975-05-22

Similar Documents

Publication Publication Date Title
MY100343A (en) Amide derivative and external medicament comprising same
GB1517480A (en) Opiate analgesic formulation with a low potential for abuse
GB1390772A (en) Oral narcotic composition
GR3019872T3 (en) Codeinsalt of a substituted carbonacid, process of its preparation, its use and pharmaceutical preparations
GB1463505A (en) Pharmaceutical compositions
HUP0105308A2 (en) Eletriptan hydrobromide monohydrate, process for its preparation and pharmaceutical compositions containing the same
BR8008818A (en) PHARMACOLOGICALLY ACTIVE PEPTIDES AND MEDICINES CONTAINING THE SAME
GB2209281B (en) Pharmaceutical compositions comprising an alpha-2 adrenoceptor antagonist
IL68525A (en) (s)and(r,s)-4-amino-hepta-5,6-dienoic acids and salts thereof,their preparation and pharmaceutical compositions containing them
GB1256723A (en)
GB1322112A (en) 3,4,5-trimethoxybenzoic acid derivatives and their uses
GB1359560A (en) Preparation of pyrrylsalicylic acid
GB1394757A (en) Lysino-calcium chloride
GB1486395A (en) Cardiac stimulant
GB1503577A (en) Vincadioline
GB1467117A (en) Pharmaceutical compositions with anti-parkinson effects and a process for the preparation thereof
GB1351437A (en) N-substituted amino acids having antiviral anti-inflammatory or anti-tumour activity
GB1261660A (en) alpha-HYDRAZINO ACIDS
GB1420976A (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
GB1050565A (en)
GB1390091A (en) 4-4-biphenylyl-butyric acid derivatives
DE3472554D1 (en) Cysteine derivatives, a process for their preparation, and pharmaceutical compostions which contain them
ES8304924A1 (en) Peptide, process for preparation thereof and use thereof.
GB1317234A (en) Method of inhibiting the hydrolysis of acetylsalicyclic acid and d-propyxyphene hydrochloride
GB1417807A (en) Pharmaceutically acitve compounds

Legal Events

Date Code Title Description
PS Patent sealed
704A Declaration that licence is not available as of right for an excepted use (par. 4a/1977)
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
PE20 Patent expired after termination of 20 years

Effective date: 19941106